The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab combined with rivoceranib and TACE in the perioperative treatment of hepatocellular carcinoma: A randomized, open-label multicenter trial.
 
Yongxiang Xia
No Relationships to Disclose
 
Xiaofeng Wu
No Relationships to Disclose
 
Aihua Yao
No Relationships to Disclose
 
Xiaofeng Qian
No Relationships to Disclose
 
Xinzheng Dai
No Relationships to Disclose
 
Feng Zhang
No Relationships to Disclose
 
Ke Wang
No Relationships to Disclose
 
Chuanyong Zhang
No Relationships to Disclose
 
Liyong Pu
No Relationships to Disclose
 
Donghua Li
No Relationships to Disclose
 
Ping Wang
No Relationships to Disclose
 
Feng Cheng
No Relationships to Disclose
 
Jie Zhao
No Relationships to Disclose
 
Hui Zhang
No Relationships to Disclose
 
Weiwei Tang
No Relationships to Disclose
 
Yongxiang Zhan
No Relationships to Disclose
 
Jinxue Zhou
No Relationships to Disclose
 
Bin Zhang
No Relationships to Disclose
 
Xiangcheng Li
No Relationships to Disclose
 
Xuehao Wang
No Relationships to Disclose